Lincoln International's Global Healthcare Group Announces Record Year - Lincoln International LLC

Lincoln International’s Global Healthcare Group Announces Record Year

Lincoln International remains one of the most active healthcare M&A advisors in 2021

Lincoln International’s global healthcare mergers and acquisitions (M&A) activity in 2021 eclipsed that of 2020 led by the firm’s growing sector capabilities and strong appetite for deals. In 2021, we completed transactions with or on behalf of some of the largest and most well-known names in healthcare private equity. Lincoln’s reputation for advising on, executing and closing high-quality assignments across healthcare services, life sciences, pharma outsourcing, medical products and healthcare information technology (IT) continues to strengthen. Lincoln is one of the only investment banks with dedicated, senior healthcare bankers covering markets across the Americas, Europe and Asia.

Summary

Lincoln International's global Healthcare Group celebrates record results in 2021.

Select Notable 2021 Healthcare Transactions

ARK OPEN Health Amulet Capital 2021

Lincoln International is pleased to announce that ARK Agency has been sold to OPEN Health, a portfolio company of Amulet Capital Partners

Pharmarack DigiHealth Technologies 2021

Lincoln International advised Pharmarack Technologies in its sale to DigiHealth Technologies LLP

Enhanced Healthcare Partners MedTest DX Horiba 2021

Lincoln International is pleased to announce MedTest Holdings, a portfolio company of Enhanced Healthcare Partners, has been sold to HORIBA

Harbour Group Indsutries SP Industries ATS Automation Tooling Systems 2021

Lincoln International advised Harbour Group on the sale of SP Industries to ATS Automation Tooling Systems

Magnetar Financial KIMS Hospital LycaHealth 2021

Lincoln International is pleased to announce that KIMS Hospital has been sold to LycaHealth

BondVet Warburg Pincus

Lincoln International advised Bond Vet in the receipt of a significant investment from Warburg Pincus

Novozymes Synergia Life Sciences 2021

Lincoln international is pleased to announce that Novozymes (CPSE:NZYM B) has acquired a majority stake in Synergia Life Sciences

Lincoln International advised on the sale of Caring Brands International, a portfolio company of Levine Leichtman Capital Partners, to Wellspring Capital Management

Kinderzimmer Franz Haniel 2021

Lincoln International is pleased to announce that it has advised the founders and shareholders of KMK Kinderzimmer on the sale of a majority stake to Franz Haniel & Cie.

New Harbor Wedgewood PartnersGroup 2020

Lincoln International advised New Harbor Capital on the sale of Wedgewood Pharmacy to Partners Group

H&T Presspart Novelex Liberta Partners 2021

Lincoln International is pleased to announce that it has advised H&T Presspart on the acquisition of novelex AG from Liberta Partners

Lincoln International advised on the sale of The PromptCare Companies, a portfolio company of The Halifax Group, to Waud Capital Partners

Click here to view more recent healthcare transactions

Related Perspectives

Real Deals | Healthcare M&A Resilience

What trends have you seen in the last quarter in relation to valuations in the healthcare space? Matthew Lee: It’s early days to get an accurate read on valuations as… Read More

Lincoln International Announces Strategic Partnership with Australian Corporate Advisory Firm, Miles Advisory Partners

Lincoln International, a global investment banking advisory firm, announced today that it has established a strategic partnership with Miles Advisory Partners, an Australian-based independent corporate advisory firm, servicing the robust… Read More

Lincoln International’s Global Healthcare Group Announces Strong Results in 2022

Lincoln International’s global Healthcare Group enjoyed another consecutive year of record-setting mergers and acquisitions (M&A) deal volume, average deal size and a record backlog heading in to 2023. Our performance… Read More

Scrip | What Does 2023 Hold for Biopharma? Part 6: Artificial Intelligence

Originally posted by Scrip on February 10, 2023. Tony Crisman, Managing Director in Lincoln’s Healthcare Group, shares his predictions for artificial intelligence in the biopharma industry. View the original article.

View All Perspectives

Meet Our Senior Team

Sound advice coupled with deep sector knowledge and international reach is how I add value and lead to successful outcomes for my clients.

Gunnar Brundin

Managing Director

Stockholm

I seek to understand client needs and goals, and work tirelessly to deliver options that achieve outcomes they deserve, while cultivating a relaxed, open and consultative relationship.

Anthony Crisman

Managing Director

Chicago

The healthcare market is ever-changing and increasingly complex and always puts one in touch with exceptional people of many talents.

Shahab Fatheazam

Vice Chairman | Healthcare

Chicago

I am a fierce, tireless advocate for my clients in securing world-class outcomes on their transactions.

Barry Freeman

Managing Director

Chicago

Honesty and integrity are very important to me. I have a genuine interest in learning about clients and their businesses, as well as pushing myself to continuously evolve in my role as a valued advisor.

Cynthya Goulet

Managing Director

Chicago

I am humbled and awed by the impressive businesses that our clients spend many years of their lives building. It is a great honor and a very serious thing when a client hires us to advise them.

Nick Konstantinou

Managing Director

Chicago

It’s extremely rewarding to work in one of the largest and most diverse global business sectors helping support clients to realize their goals.

Matthew Lee

Managing Director

London

I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.

Dirk-Oliver Löffler

Managing Director | Management Board Member

Frankfurt

The opportunity to advise accomplished business professionals and be part of their growth story and value creation is what keeps me inspired to work in this industry

Gaurav Marathe

Managing Director | CEO India

Mumbai

My goal is to bring the best of Lincoln to each and every transaction, ensuring the topmost outcomes for our clients.

Roderick O’Neill

Managing Director

New York

I strive to be a trusted advisor to my clients, adding value throughout their journey, and helping them to reach successful outcomes.

François Rispoli

Managing Director

Paris

I enjoy partnering with disruptive healthcare technology businesses and executives, providing support to achieve their long-term growth objectives in their pursuit to revolutionize the industry.

Derek Ritchea

Managing Director

New York

Back to Top